ferric citrate has been researched along with Anemias, Iron-Deficiency in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (3.13) | 18.2507 |
| 2000's | 2 (6.25) | 29.6817 |
| 2010's | 21 (65.63) | 24.3611 |
| 2020's | 8 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chua, K; Czaya, B; Gabayan, V; Ganz, T; Hanudel, MR; Jung, G; Namjoshi, S; Nemeth, E; Qiao, B; Rappaport, M; Wong, S | 1 |
| Akizawa, T; Arita, K; Hanaki, K; Komatsu, N; Mitsui, H; Nemoto, T | 1 |
| Chiu, YW; Lee, CC; Lee, CT; Leu, JG; Peng, YS; Tarng, DC; Wu, MJ; Wu, MS | 1 |
| Haase, VH | 1 |
| Fishbane, S; Ganz, T; Pergola, PE | 1 |
| Hanudel, MR | 1 |
| Iida, A; Matsushita, M; Ohta, T; Yamada, T | 1 |
| Choi, YJ; Noh, Y; Shin, S | 1 |
| Arita, K; Hanaki, K; Komatsu, N; Mitsui, H; Nemoto, T | 1 |
| Belo, D; Crawford, P; Farag, YMK; Goldfarb-Rumyantzev, A; Luo, W; Moustafa, M; Pergola, PE | 1 |
| Iguchi, A; Kazama, JJ; Narita, I; Suzuki, Y; Tasaki, K; Yamamoto, S; Yamazaki, M | 1 |
| Block, GA; Chertow, GM; Fishbane, S; Neylan, JF; Pergola, PE; Uhlig, K | 1 |
| Block, GA; Chertow, GM; Fishbane, S; LeWinter, RD; Neylan, JF; Pergola, PE; Uhlig, K | 1 |
| Gales, B; Hanudel, MR; Laster, M; Ramos, G; Salusky, IB | 1 |
| Fishbane, S; McCullough, PA; Neylan, JF; Pergola, PE; Uhlig, K | 1 |
| Block, GA; Chertow, GM; Fishbane, S; LeWinter, RD; Martins, JG; Neylan, JF; Pergola, PE; Uhlig, K | 1 |
| Staniek, H | 1 |
| Bino, A; Ganz, T; Salusky, IB | 1 |
| Block, GA; Block, MS; Chertow, GM; Isakova, T; Mehta, R; Smits, G; Wolf, M | 1 |
| Giri, K; Jain, D; Nand, N | 1 |
| Chang, Y; Chen, J; Duan, X; Ge, L; Geng, L; Yu, P; Yuan, L | 1 |
| Athreya, BP; Blumenthal, SS; Chang, IJ; Chuang, P; Dwyer, JP; Galphin, CM; Greene, T; Kant, KS; Koury, MJ; Lewis, JB; Linfert, DR; Manley, J; Nossuli, AK; Olivero, JJ; Schulman, G; Sika, M; Smith, MT; Whittier, FC; Zeig, S | 1 |
| Block, GA; Chertow, GM; Fishbane, S; Pergola, PE; Rodriguez, M; Shemesh, S; Smits, G; Wolf, M | 1 |
| Cournoyer, SH; Fanti, P; Fishbane, SN; Gupta, A; Guss, CD; Jindal, KK; Lin, VH; Pratt, RD; Singh, AK | 1 |
| Iguchi, A; Iino, N; Kazama, JJ; Narita, I; Watanabe, Y; Yamamoto, S; Yoshita, K | 1 |
| Fishbane, S; Hazzan, AD; Shah, HH | 1 |
| Vaziri, ND | 1 |
| Block, GA | 1 |
| Konomi, A; Otagi, M; Yokoi, K | 1 |
| Glahn, RP; Hoekenga, OA; Kochian, LV; Tako, E | 1 |
| Fukuda, K; Hata, Y; Irie, M; Suzuki, S | 1 |
| Alférez, MJ; Barrionuevo, M; Campos, MS; Gómez-Ayala, AE; Hartiti, S; Lisbona, F; López-Aliaga, I; Moratalla, A; Pallarés, I | 1 |
6 review(s) available for ferric citrate and Anemias, Iron-Deficiency
| Article | Year |
|---|---|
Novel Oral Iron Therapies for Iron Deficiency Anemia in Chronic Kidney Disease.
Topics: Administration, Oral; Anemia, Iron-Deficiency; Ferric Compounds; Hematinics; Humans; Pyrones; Renal Insufficiency, Chronic | 2019 |
Ferric citrate in the management of hyperphosphataemia and iron deficiency anaemia: A meta-analysis in patients with chronic kidney disease.
Topics: Anemia, Iron-Deficiency; Ferric Compounds; Humans; Hyperphosphatemia; Phosphates; Renal Insufficiency, Chronic | 2021 |
Mechanism of Action and Clinical Attributes of Auryxia
Topics: Administration, Intravenous; Anemia, Iron-Deficiency; Cardiovascular Diseases; Chelating Agents; Clinical Trials as Topic; Ferric Compounds; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperphosphatemia; Iron; Iron Overload; Phosphates; Renal Insufficiency, Chronic; Risk Factors; Treatment Outcome | 2019 |
Ferric Pyrophosphate Citrate: A Novel Iron Replacement Agent in Patients Undergoing Hemodialysis.
Topics: Anemia, Iron-Deficiency; Dialysis Solutions; Diphosphates; Ferric Compounds; Hematinics; Humans; Iron; Kidney Failure, Chronic; Renal Dialysis | 2016 |
Safety Issues in Iron Treatment in CKD.
Topics: Anemia, Iron-Deficiency; Cardiovascular Diseases; Cognitive Dysfunction; Diabetes Mellitus, Type 2; Disease Progression; Ferric Compounds; Hematinics; Humans; Iron Compounds; Iron Overload; Kidney Failure, Chronic; Oxidative Stress; Reactive Oxygen Species; Renal Dialysis; Renal Insufficiency, Chronic | 2016 |
Ferric Citrate in Patients With Chronic Kidney Disease.
Topics: Anemia, Iron-Deficiency; Ferric Compounds; Hematinics; Humans; Kidney Failure, Chronic; Renal Dialysis; Renal Insufficiency, Chronic | 2016 |
11 trial(s) available for ferric citrate and Anemias, Iron-Deficiency
| Article | Year |
|---|---|
Efficacy and safety of ferric citrate hydrate compared with sodium ferrous citrate in Japanese patients with iron deficiency anemia: a randomized, double-blind, phase 3 non-inferiority study.
Topics: Adult; Anemia, Iron-Deficiency; Citric Acid; Double-Blind Method; Ferric Compounds; Ferrous Compounds; Humans; Japan; Middle Aged; Treatment Outcome | 2021 |
Ferric Citrate Dosing in Iron Deficiency Anemia in Nondialysis-Dependent Chronic Kidney Disease.
Topics: Adult; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Female; Ferric Compounds; Fibroblast Growth Factor-23; Glomerular Filtration Rate; Hemoglobins; Humans; Male; Middle Aged; Phosphates; Renal Insufficiency, Chronic; Time Factors | 2021 |
Effect of ferric citrate hydrate on FGF23 and PTH levels in patients with non-dialysis-dependent chronic kidney disease with normophosphatemia and iron deficiency.
Topics: Aged; Anemia, Iron-Deficiency; Female; Ferric Compounds; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Japan; Male; Middle Aged; Parathyroid Hormone; Renal Insufficiency, Chronic; Tokyo | 2018 |
Safety and efficacy of ferric citrate in patients with nondialysis-dependent chronic kidney disease.
Topics: Adult; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Dose-Response Relationship, Drug; Female; Ferric Compounds; Humans; Kidney Failure, Chronic; Male; Middle Aged; Placebos | 2017 |
Hemoglobin response to ferric citrate in patients with nondialysis-dependent chronic kidney disease and iron deficiency anemia.
Topics: Anemia, Iron-Deficiency; Ferric Compounds; Hemoglobins; Humans; Renal Insufficiency, Chronic | 2018 |
Usefulness of Oral Ferric Citrate in Patients With Iron-Deficiency Anemia and Chronic Kidney Disease With or Without Heart Failure.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Biomarkers; Dose-Response Relationship, Drug; Double-Blind Method; Female; Ferric Compounds; Ferritins; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Renal Insufficiency, Chronic; Treatment Outcome; Young Adult | 2018 |
Effect of ferric citrate on serum phosphate and fibroblast growth factor 23 among patients with nondialysis-dependent chronic kidney disease: path analyses.
Topics: Aged; Anemia, Iron-Deficiency; Biomarkers; Double-Blind Method; Enzyme-Linked Immunosorbent Assay; Female; Ferric Compounds; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Follow-Up Studies; Humans; Male; Phosphates; Renal Dialysis; Renal Insufficiency, Chronic | 2019 |
A Pilot Randomized Trial of Ferric Citrate Coordination Complex for the Treatment of Advanced CKD.
Topics: Aged; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferritins; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glomerular Filtration Rate; Hemoglobins; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Length of Stay; Male; Middle Aged; Patient Admission; Phosphates; Pilot Projects; Renal Dialysis; Transferrin | 2019 |
Ferric citrate controls phosphorus and delivers iron in patients on dialysis.
Topics: Anemia, Iron-Deficiency; Dose-Response Relationship, Drug; Female; Ferric Compounds; Humans; Hyperphosphatemia; Iron; Israel; Kidney Failure, Chronic; Male; Middle Aged; Outcome Assessment, Health Care; Phosphorus; Renal Dialysis; Treatment Outcome; United States | 2015 |
A 12-week, double-blind, placebo-controlled trial of ferric citrate for the treatment of iron deficiency anemia and reduction of serum phosphate in patients with CKD Stages 3-5.
Topics: Aged; Anemia, Iron-Deficiency; Disease Progression; Double-Blind Method; Female; Ferric Compounds; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Hematinics; Humans; Male; Middle Aged; Phosphates; Renal Insufficiency, Chronic | 2015 |
Ferric pyrophosphate citrate (Triferic™) administration via the dialysate maintains hemoglobin and iron balance in chronic hemodialysis patients.
Topics: Administration, Intravenous; Anemia, Iron-Deficiency; Dialysis Solutions; Dietary Supplements; Diphosphates; Female; Ferric Compounds; Hematinics; Hemoglobins; Humans; Iron; Male; Middle Aged; Prospective Studies; Renal Dialysis; Single-Blind Method; Treatment Outcome | 2015 |
15 other study(ies) available for ferric citrate and Anemias, Iron-Deficiency
| Article | Year |
|---|---|
Enteral ferric citrate absorption is dependent on the iron transport protein ferroportin.
Topics: Anemia, Iron-Deficiency; Animals; Cation Transport Proteins; Ferric Compounds; Hepcidins; Humans; Iron; Mice | 2022 |
[The effect of ferric citrate hydrate as an iron replacement therapy in Japanese patients with iron deficiency anemia].
Topics: Anemia, Iron-Deficiency; Ferric Compounds; Humans; Iron; Iron Deficiencies; Japan | 2021 |
Long-term safety and efficacy of ferric citrate in phosphate-lowering and iron-repletion effects among patients with on hemodialysis: A multicenter, open-label, Phase IV trial.
Topics: Anemia, Iron-Deficiency; Ferric Compounds; Ferritins; Humans; Iron; Phosphates; Phosphorus; Renal Dialysis | 2022 |
The ins and outs of ferric citrate.
Topics: Anemia, Iron-Deficiency; Ferric Compounds; Humans; Hyperphosphatemia; Iron | 2022 |
Ferric citrate: cardio- and renoprotective in chronic kidney disease?
Topics: Anemia, Iron-Deficiency; Animals; Ferric Compounds; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Mice; Renal Insufficiency, Chronic | 2019 |
Conventional and novel impacts of ferric citrate on iron deficiency anemia and phosphorus metabolism in rats.
Topics: Administration, Oral; Anemia, Iron-Deficiency; Animals; Ferric Compounds; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Iron Deficiencies; Male; Phosphorus; Rats, Sprague-Dawley | 2020 |
Clinical experience with the use of ferric citrate as a phosphate binder in pediatric dialysis patients.
Topics: Adolescent; Anemia, Iron-Deficiency; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Ferric Compounds; Humans; Hyperphosphatemia; Male; Off-Label Use; Phosphates; Renal Dialysis; Renal Insufficiency, Chronic; Retrospective Studies; Treatment Outcome | 2018 |
The Combined Effects of Cr(III) Supplementation and Iron Deficiency on the Copper and Zinc Status in Wistar Rats.
Topics: Anemia, Iron-Deficiency; Animals; Body Weight; Chromium Compounds; Copper; Dietary Supplements; Disease Models, Animal; Dose-Response Relationship, Drug; Eating; Female; Ferric Compounds; Rats; Rats, Wistar; Structure-Activity Relationship; Zinc | 2019 |
Role of Ferric Citrate in Hyperphosphatemia and Iron Deficiency Anemia in Non Dialysis CKD Patients.
Topics: Adult; Anemia, Iron-Deficiency; Ferric Compounds; Humans; Hyperphosphatemia; India; Prospective Studies; Renal Dialysis; Renal Insufficiency, Chronic | 2019 |
Effect of iron liposomes on anemia of inflammation.
Topics: Administration, Oral; Anemia, Iron-Deficiency; Animals; Chemistry, Pharmaceutical; Disease Models, Animal; Ferric Compounds; Hematinics; Heme; Hepcidins; Inflammation; Intestinal Absorption; Iron; Liposomes; Male; Rats; Rats, Sprague-Dawley; Technology, Pharmaceutical; Time Factors; Ultrasonics | 2013 |
Administration of Ferric Citrate Hydrate Decreases Circulating FGF23 Levels Independently of Serum Phosphate Levels in Hemodialysis Patients with Iron Deficiency.
Topics: 25-Hydroxyvitamin D 2; Adult; Aged; Anemia, Iron-Deficiency; Bone Diseases; Chelating Agents; Female; Ferric Compounds; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphates; Prospective Studies; Renal Dialysis; Sevelamer; Young Adult | 2015 |
Iron bioavailability of cocoa powder as determined by the Hb regeneration efficiency method.
Topics: Anemia, Iron-Deficiency; Animals; Animals, Newborn; Biological Availability; Body Weight; Cacao; Ferric Compounds; Ferrous Compounds; Hematinics; Hemoglobins; Iron, Dietary; Male; Models, Animal; Rats; Rats, Inbred F344; Weaning | 2009 |
High bioavailability iron maize (Zea mays L.) developed through molecular breeding provides more absorbable iron in vitro (Caco-2 model) and in vivo (Gallus gallus).
Topics: Anemia, Iron-Deficiency; Animals; Biological Availability; Caco-2 Cells; Cation Transport Proteins; Chickens; Cytochrome b Group; Diet; DNA Shuffling; Ferric Compounds; Food, Fortified; Gene Expression; Hemoglobins; Humans; Iron, Dietary; Liver; Oxidoreductases; Phytic Acid; RNA, Messenger; Zea mays | 2013 |
Iron chelated cyclic peptide, ferrichrysin, for oral treatment of iron deficiency: solution properties and efficacy in anemic rats.
Topics: Anemia, Iron-Deficiency; Animals; Dietary Supplements; Ferric Compounds; Ferrichrome; Heme; Hydrogen-Ion Concentration; Iron; Liver; Male; Rats; Rats, Sprague-Dawley; Solubility; Weight Gain | 2007 |
Effects of iron replenishment on iron, calcium, phosphorus and magnesium metabolism in iron-deficient rats.
Topics: Analysis of Variance; Anemia, Iron-Deficiency; Animal Feed; Animals; Ascorbic Acid; Body Weight; Calcium; Eating; Ferric Compounds; Ferrous Compounds; Food, Fortified; Hemoglobins; Iron; Iron Deficiencies; Magnesium; Male; Phosphorus; Random Allocation; Rats; Rats, Wistar; Tissue Distribution | 1996 |